DALOSIRVAT, SM04554, and SETIPIPRANT all work by inhibiting the production of PGD2, a protein that can interfere with the growth of hair follicles. This is the most common type of hair loss, affecting around 50 million men in the United States. PGD2 is naturally produced in the skin and is thought to be responsible for the inflammation that causes hair loss. Drugs like DALOSIRVAT, SM04554, and SETIPIPRANT inhibit the production of PGD2, protecting hair follicles from the harmful effects of inflammation and encouraging hair growth.
There are no reviews yet.